Acasti Pharma Inc
General ticker "ACST" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $34.9M
Acasti Pharma Inc follows the US Stock Market performance with the rate: 23.4%.
Estimated limits based on current volatility of 5.2%: low 3.06$, high 3.40$
Factors to consider:
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [2.29$, 4.33$]
- 2025-03-31 to 2026-03-31 estimated range: [2.18$, 4.17$]
Short-term ACST quotes
Long-term ACST plot with estimates
Financial data
| YTD | 2024-03-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $11.31MM |
| Operating Income | $-11.31MM |
| Non-Operating Income | $-3.32MM |
| Interest Expense | $0.91MM |
| R&D Expense | $4.63MM |
| Income(Loss) | $-14.63MM |
| Taxes | $-1.78MM |
| Profit(Loss) | $-12.85MM |
| Stockholders Equity | $61.74MM |
| Assets | $73.30MM |
| Operating Cash Flow | $-12.33MM |
| Investing Cash Flow | $0.10MM |
| Financing Cash Flow | $7.36MM |
| Earnings Per Share* | $-1.35 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.